<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gallardo-Godoy</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gever</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Fife</surname>
    <given-names>KL</given-names>
   </name>
   <name>
    <surname>Silber</surname>
    <given-names>BM</given-names>
   </name>
   <name>
    <surname>Prusiner</surname>
    <given-names>SB</given-names>
   </name>
   <name>
    <surname>Renslo</surname>
    <given-names>AR</given-names>
   </name>
  </person-group>
  <article-title>2-aminothiazoles as therapeutic leads for prion diseases</article-title>
  <source>J Medicinal Chem</source>
  <year>2011</year>
  <volume>54</volume>
  <fpage>1010</fpage>
  <lpage>21</lpage>
  <pub-id pub-id-type="doi">10.1021/jm101250y</pub-id>
 </element-citation>
</ref>
